Finally, group 10 acted as a vehicle control for Dihexa in group 8 and received local MSC and DMSO via hydrogel, and intravenous injection of MSC, and an injection into the gastrocnemius muscle with MSC and DMSO [2]
Provider-supported medical weight management options may include semaglutide or tirzepatide when clinically appropriate
No single molecular pathway independently controls matrix remodeling, cellular migration, vascular signaling, epithelial behavior and inflammatory-response signaling
The Common (and Manageable) Side Effects The most frequent side effects of GLP-1 receptor agonists are gastrointestinal nausea, bloating, constipation, or diarrhoea particularly when first starting or increasing the dose
Recent articles Nutrition Weight Management For Employers Beyond weight loss: the expanding research on GLP-1s 6/25/2026 For Employers GLP-1 trends employers should know in 2026 4/21/2026 Featured Medications Weight Management New weight loss pills: what the latest FDA approvals mean 4/15/2026 Get the latest tips to your inbox
The same physiology that drives these benefits, particularly delayed gastric emptying, also explains many of the complications seen in the ED
/assets/production/practices/8b0d3bb90a4a057da79711c047bb7841fe69b974/images/2795992.jpg)
